Cargando…

Comparison of high-performance liquid chromatography and ultraviolet-visible spectrophotometry to determine the best method to assess Levofloxacin released from mesoporous silica microspheres/nano-hydroxyapatite composite scaffolds

An assessment of Levofloxacin by high-performance liquid chromatography (HPLC) or ultraviolet-visible spectrophotometry (UV-Vis) and its pharmacokinetics in serum or plasma was made in a previous study by the present authors. Levofloxacin-loaded mesoporous silica microspheres/nano-hydroxyapatite (n-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Wang, Guodong, Xie, Shicheng, Zhao, Xiaowei, Zhang, Yuanmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425260/
https://www.ncbi.nlm.nih.gov/pubmed/30906459
http://dx.doi.org/10.3892/etm.2019.7238
_version_ 1783404807738884096
author Wang, Qi
Wang, Guodong
Xie, Shicheng
Zhao, Xiaowei
Zhang, Yuanmin
author_facet Wang, Qi
Wang, Guodong
Xie, Shicheng
Zhao, Xiaowei
Zhang, Yuanmin
author_sort Wang, Qi
collection PubMed
description An assessment of Levofloxacin by high-performance liquid chromatography (HPLC) or ultraviolet-visible spectrophotometry (UV-Vis) and its pharmacokinetics in serum or plasma was made in a previous study by the present authors. Levofloxacin-loaded mesoporous silica microspheres/nano-hydroxyapatite (n-HA) composite scaffolds comprise a novel synthetic composite scaffold that may be utilized as a drug-delivery system for clinical usage. However, few studies have been published concerning a comparison of HPLC with UV-Vis, which is the preferred method for determination of Levofloxacin. In the present study, an HPLC method was first established, and subsequently a comparison of HPLC with the UV-Vis method was performed. The standard curve was established, and recovery rate from simulated body fluid was calculated. The linear concentration range for Levofloxacin was 0.05–300 µg/ml. The regression equation for HPLC was y=0.033x+0.010, with R(2)=0.9991, whereas that for UV-Vis was y=0.065x+0.017, with R(2)=0.9999. The recovery rates of low, medium and high (5, 25 and 50 µg/ml) concentrations of Levofloxacin determined by HPLC were 96.37±0.50, 110.96±0.23 and 104.79±0.06%, respectively, whereas those for low, medium and high concentrations according to UV-Vis were 96.00±2.00, 99.50±0.00 and 98.67±0.06%, respectively. Taken together, these findings demonstrated that it is not accurate to measure the concentration of drugs loaded on the biodegradable composite composites by UV-Vis. HPLC is the preferred method to evaluate sustained release characteristics of Levofloxacin released from mesoporous silica microspheres/n-HA composite scaffolds. The present study also provides guidance on which methods should be selected for investigating the sustained release properties of drugs in tissue engineering. The accurate determination of drug concentration in the drug delivery system provides guidance for the treatment of infectious diseases.
format Online
Article
Text
id pubmed-6425260
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-64252602019-03-22 Comparison of high-performance liquid chromatography and ultraviolet-visible spectrophotometry to determine the best method to assess Levofloxacin released from mesoporous silica microspheres/nano-hydroxyapatite composite scaffolds Wang, Qi Wang, Guodong Xie, Shicheng Zhao, Xiaowei Zhang, Yuanmin Exp Ther Med Articles An assessment of Levofloxacin by high-performance liquid chromatography (HPLC) or ultraviolet-visible spectrophotometry (UV-Vis) and its pharmacokinetics in serum or plasma was made in a previous study by the present authors. Levofloxacin-loaded mesoporous silica microspheres/nano-hydroxyapatite (n-HA) composite scaffolds comprise a novel synthetic composite scaffold that may be utilized as a drug-delivery system for clinical usage. However, few studies have been published concerning a comparison of HPLC with UV-Vis, which is the preferred method for determination of Levofloxacin. In the present study, an HPLC method was first established, and subsequently a comparison of HPLC with the UV-Vis method was performed. The standard curve was established, and recovery rate from simulated body fluid was calculated. The linear concentration range for Levofloxacin was 0.05–300 µg/ml. The regression equation for HPLC was y=0.033x+0.010, with R(2)=0.9991, whereas that for UV-Vis was y=0.065x+0.017, with R(2)=0.9999. The recovery rates of low, medium and high (5, 25 and 50 µg/ml) concentrations of Levofloxacin determined by HPLC were 96.37±0.50, 110.96±0.23 and 104.79±0.06%, respectively, whereas those for low, medium and high concentrations according to UV-Vis were 96.00±2.00, 99.50±0.00 and 98.67±0.06%, respectively. Taken together, these findings demonstrated that it is not accurate to measure the concentration of drugs loaded on the biodegradable composite composites by UV-Vis. HPLC is the preferred method to evaluate sustained release characteristics of Levofloxacin released from mesoporous silica microspheres/n-HA composite scaffolds. The present study also provides guidance on which methods should be selected for investigating the sustained release properties of drugs in tissue engineering. The accurate determination of drug concentration in the drug delivery system provides guidance for the treatment of infectious diseases. D.A. Spandidos 2019-04 2019-02-04 /pmc/articles/PMC6425260/ /pubmed/30906459 http://dx.doi.org/10.3892/etm.2019.7238 Text en Copyright: © Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Wang, Qi
Wang, Guodong
Xie, Shicheng
Zhao, Xiaowei
Zhang, Yuanmin
Comparison of high-performance liquid chromatography and ultraviolet-visible spectrophotometry to determine the best method to assess Levofloxacin released from mesoporous silica microspheres/nano-hydroxyapatite composite scaffolds
title Comparison of high-performance liquid chromatography and ultraviolet-visible spectrophotometry to determine the best method to assess Levofloxacin released from mesoporous silica microspheres/nano-hydroxyapatite composite scaffolds
title_full Comparison of high-performance liquid chromatography and ultraviolet-visible spectrophotometry to determine the best method to assess Levofloxacin released from mesoporous silica microspheres/nano-hydroxyapatite composite scaffolds
title_fullStr Comparison of high-performance liquid chromatography and ultraviolet-visible spectrophotometry to determine the best method to assess Levofloxacin released from mesoporous silica microspheres/nano-hydroxyapatite composite scaffolds
title_full_unstemmed Comparison of high-performance liquid chromatography and ultraviolet-visible spectrophotometry to determine the best method to assess Levofloxacin released from mesoporous silica microspheres/nano-hydroxyapatite composite scaffolds
title_short Comparison of high-performance liquid chromatography and ultraviolet-visible spectrophotometry to determine the best method to assess Levofloxacin released from mesoporous silica microspheres/nano-hydroxyapatite composite scaffolds
title_sort comparison of high-performance liquid chromatography and ultraviolet-visible spectrophotometry to determine the best method to assess levofloxacin released from mesoporous silica microspheres/nano-hydroxyapatite composite scaffolds
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425260/
https://www.ncbi.nlm.nih.gov/pubmed/30906459
http://dx.doi.org/10.3892/etm.2019.7238
work_keys_str_mv AT wangqi comparisonofhighperformanceliquidchromatographyandultravioletvisiblespectrophotometrytodeterminethebestmethodtoassesslevofloxacinreleasedfrommesoporoussilicamicrospheresnanohydroxyapatitecompositescaffolds
AT wangguodong comparisonofhighperformanceliquidchromatographyandultravioletvisiblespectrophotometrytodeterminethebestmethodtoassesslevofloxacinreleasedfrommesoporoussilicamicrospheresnanohydroxyapatitecompositescaffolds
AT xieshicheng comparisonofhighperformanceliquidchromatographyandultravioletvisiblespectrophotometrytodeterminethebestmethodtoassesslevofloxacinreleasedfrommesoporoussilicamicrospheresnanohydroxyapatitecompositescaffolds
AT zhaoxiaowei comparisonofhighperformanceliquidchromatographyandultravioletvisiblespectrophotometrytodeterminethebestmethodtoassesslevofloxacinreleasedfrommesoporoussilicamicrospheresnanohydroxyapatitecompositescaffolds
AT zhangyuanmin comparisonofhighperformanceliquidchromatographyandultravioletvisiblespectrophotometrytodeterminethebestmethodtoassesslevofloxacinreleasedfrommesoporoussilicamicrospheresnanohydroxyapatitecompositescaffolds